🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine if Serostim® 4 mg admini...
Status
Completed
Location
University of Alabama/Birmingham
Start Date
2004-05-28
Trial ID
NCT00082628
Treatments Being Tested
This is an open-label, single-arm, multicenter, Phase 4 study to explore th...
Status
Completed
Location
Research site
Start Date
2013-06
Trial ID
NCT01806298
Treatments Being Tested
This is a Phase IV, open label, case-controlled, observational study to eva...
Status
Terminated
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01243892
Treatments Being Tested
Cure rates for childhood malignancies have improved at a remarkable pace.Wi...
Status
Unknown
Location
The Leeds Teaching Hospitals NHS Trust
Start Date
2010-10
Trial ID
NCT02629926
Treatments Being Tested
To assess the immunogenicity of Saizen® solution for injection in adult sub...
Status
Terminated
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01237340
Treatments Being Tested
A study demonstrates the non-inferiority of DA-3002 when compared with Geno...
Status
Completed
Location
Samsung Medical Center
Start Date
2013-02
Trial ID
NCT01813630
Treatments Being Tested
IGF-1 (insulin-like growth factor-1) is a hormone that is normally produced...
Status
Terminated
Location
Ipsen
Start Date
2007-12
Trial ID
NCT00572156
Treatments Being Tested
This one-arm, multi-centric, non-randomized, observational, open label, pro...
Status
Completed
Location
Merck Serono Investigational Site
Start Date
2009-03
Trial ID
NCT01082354
Treatments Being Tested
The overall aim of this study is to investigate the effects of GH treatment...
Status
Completed
Location
Centrum for Endocrinology and Metabolism, Sahlgenska University Hospital
Start Date
1999-01
Trial ID
NCT00781547
Treatments Being Tested
To check how safe and well-tolerated a single subcutaneous injection of Gen...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-06-09
Trial ID
NCT07016802
Treatments Being Tested